Metabolomics of Multiple System Atrophy Patient-Derived Striatal Medium Spiny Neurons

Area of Science:

• Neuroscience
• Biochemistry
• Cell Biology

Background:

• Multiple system atrophy (MSA) is a fatal neurodegenerative disorder characterized by striatal and subcortical cell loss, leading to atypical Parkinsonism.
• Pathophysiology involves alpha-synuclein misfolding and aggregation, neuronal hypoexcitability, and impaired mitochondrial respiratory chain activity.
• Dysregulation in Coenzyme Q10 biosynthesis enzymes has also been observed in MSA stem-cell models.

Purpose of the Study:

• To investigate metabolic alterations in the citrate cycle and mitochondrial respiratory chain in patient-derived neurons from Multiple System Atrophy (MSA).
• To analyze metabolomic profiles of GABAergic striatal medium spiny neurons from MSA patients compared to healthy controls.

Main Methods:

• Performed untargeted and targeted metabolome analyses on human stem-cell-derived GABAergic striatal medium spiny neurons.
• Focused analysis on key components of the citrate cycle and mitochondrial respiratory chain.
• Compared metabolite levels and ratios between MSA patient-derived cell lines and matched healthy controls.

Main Results:

• Observed a significant decrease in succinate levels in MSA cell lines.
• Detected a significant reduction in Adenosine Triphosphate (ATP) levels in MSA cell lines.
• Identified an imbalanced NAD+/NADH ratio in MSA cell lines compared to controls, indicating altered mitochondrial redox state.

Conclusions:

• The findings suggest significant alterations in mitochondrial processes, including the citrate cycle and respiratory chain, in MSA.
• The observed metabolic changes, particularly the decrease in succinate and ATP and the imbalanced NAD+/NADH ratio, may contribute to the neurodegeneration seen in Multiple System Atrophy.
• These results highlight mitochondrial dysfunction as a potential key factor in MSA pathogenesis.